PPARG and diabetes mellitus: Peroxisome proliferator-activated receptors (PPARs) are ligand-dependent transcription factors; drugs that activate the PPARγ subtype, increase insulin sensitization, and modulate glucose and lipid metabolism, commonly used to treat diabetes [10].